
Journal of labelled compounds and radiopharmaceuticals p. 77 - 90 (2000)
Update date:2022-08-03
Topics:
Malone, Justin A.
Reidelberger, Roger D.
Hulce, Martin
A method for the preparation of a radiolabeled CCK(A)-specific antagonist, (R)-N-pentyl-N-(4,5-di[3H]pentyl)N(α)-(3-quinolinoyl)glutamic acid amide, [3H]-A-65186, is described. (R)-γ-Benzyl-N-BOC-glutamic acid was coupled with N-(4-pentenyl)-N-pentylamine using BOPCl and TEA in dichloromethane to provide the corresponding amide. Deprotection of the α-amino moiety followed by coupling with 3-quinolinecarboxylic acid in the presence of EDCI, TEA, and HOBt in dichloromethane resulted in (R)-N-(4-pentenyl)-N-pentyl γ-benzyl-N(α)-(3-quinolinoyl)glutamic acid amide. Tritiation with concomitant hydrogenolysis of the benzyl ester proceeds smoothly to provide [3H]-A-65186.
View MoreMS( MAOSHENG )Chemical CO.,LTD
Contact:+86-519-82726678.82726378
Address:TAOXI INDUSTRY ZONE JINTAN
Contact:+86-21-56338808
Address:799 Dunhuang Road, Putuo
Contact:021
Address:Pudong
JIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD
website:http://www.xypharm.com/
Contact:+86-515-84383317
Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Guangzhou PI & PI Biotech Inc. Ltd.
Contact:+86-20-81716320
Address:13th Floor, Xinbao Technology Industrial Park, No. 2 Ruixiang Road, Huangpu District, Guangzhou,Guangdong,China
Doi:10.1016/j.tetasy.2005.05.043
(2005)Doi:10.1016/j.tetlet.2013.07.056
(2013)Doi:10.1016/S0040-4039(00)71822-3
(1975)Doi:10.1016/S0040-4039(00)80077-5
(1988)Doi:10.1021/ic2003222
(2011)Doi:10.1021/jm900611t
(2009)